SN BioScience
Latest round
- Series B
Last raised
- Jul 2020
Total raised
- $16M
Investors
- 13
About SN BioScience
Founded in 2017 and based in Seoul, South Korea, SN Biosciecne utilizes double core-shell technology to research and develop its unique anticancer drug known as 'SN-38'.
Who invested in SN BioScience
13 investors across 4 rounds
See all investors in SN BioScience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SN BioScience
Who invested in SN BioScience?
SN BioScience has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SN BioScience raised?
SN BioScience has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did SN BioScience last raise money?
SN BioScience's most recent round on record is a Series B, in Jul 2020.
What does SN BioScience do?
Founded in 2017 and based in Seoul, South Korea, SN Biosciecne utilizes double core-shell technology to research and develop its unique anticancer drug known as 'SN-38'.
Where is SN BioScience headquartered?
SN BioScience is headquartered in Seongnam, South Korea.
Which VCs invest in companies like SN BioScience?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at SN BioScience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like SN BioScience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.